Arcutis Biotherapeutics, Inc. (ARQT) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts ARQT Hot Sheet
Join SI Premium – FREE
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) reported Q2 EPS of ($0.13), $0.04 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $81.5 million versus the consensus estimate of $73.25 million.
For earnings history and earnings-related data on Arcutis Biotherapeutics, Inc. (ARQT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Starts Target Hospitality (TH) at Overweight
- Jefferies Starts Aditya Birla Real Estate (ABREL:IN) at Buy
- Goldman Sachs Reinstates Etsy (ETSY) at Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
